Example: Heart Attack

Clinical Trials Sponsored by Oraya Therapeutics, Inc

Total 6 results

NCT01521819

Unknown status

Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration

Conditions: Retinal Pigment Epithelial Detachment With Vascularization; Age Related Macular Degeneration
NCT01521065

Unknown status

An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Conditions: Age-Related Macular Degeneration; Wet Macular Degeneration; Macular Degeneration; Eye Diseases; Retinal Diseases
NCT01516294

Unknown status

IRay to Treat Polypoidal Choroidal Vasculopathy (PCV) Secondary to Age-Related Macular Degeneration (AMD

Conditions: Polypoidal Chorodial Vasculopathy; Age Related Macular Degeneration
NCT01339949

Withdrawn

Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)

Conditions: Wet Age-related Macular Degeneration; Age-related Macular Degeneration; AMD; Wet AMD; Macular Degeneration
NCT01217762

Unknown status

Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Conditions: Age-Related Macular Degeneration; Wet Age-Related Macular Degeneration; Macular Degeneration; Eye Diseases; Retinal Diseases
NCT01016873

Completed

INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD

Conditions: AMD; Wet AMD; Age-Related Macular Degeneration; Wet Age-Related Macular Degeneration; Macular Degeneration; Eye Diseases; Retinal Diseases